Maldonado LCJ, González GI

Language: Spanish
References: 20
Page: 92-97
PDF size: 513.78 Kb.

ABSTRACT

The association between a viral infection and cancer development has been documented since 1990. It’s estimated that one in five cancer cases are related to infections. The human immunodeficiency virus can predispose to the development of cancer; there are three types of cancer defining acquired immunodeficiency syndrome, which are Kaposi’s sarcoma, non-Hodgkin lymphoma, and cervical cancer. The predominant subtypes of nhl are primary central nervous system, diffuse large b-cell lymphoma and Burkitt’s lymphoma. Cytomegalovirus (CMV) is a β human herpesvirus, establishes lifelong latency. CMV in HIV accelerates disease and time of death. Here, we presented two cases of patients with lymphoma, HIV infection and CMV, where the unusual behavior of lymphoproliferative neoplasia is described.

REFERENCES

1. Limaye, A.P., Babu, T.M. y Boeckh, M., “Progress and challengesin the prevention”, Diagnosis, 2021, 34 (1): 1-37.

2. Moore, P.S. y Chang, Y., “Why do viruses cause cancer?Highlights of the first century of human tumour virology”,Nat Rev Cancer, 2010, 10: 878-889.

3. Ghosn, J., Taiwo, B., Seedat, S., Autran, B. y Katlama, C.,“vih”, Lancet, 2018, 6736 (18).

4. Hleyhel, M. et al., “Risk of aids-defining cancers amonghiv-1-infected patients in France between 1992 and2009”, Clin Infect Dis, 2013, 11: 1638-1647.

5. McMichael, A.J. y Rowland-Jones, S.L., “Cellular immuneresponses to hiv”, Natur, 2001, 410: 980-987.

6. Parkin, D.M., “The global health burden of infection-associatedcancers in the year 2002”, Int J Cancer, 2006,118: 3030-3044.

7. Marsh, J.W., Herndier, B. et al., “Cytokine expression inlarge cell lympohoma associated with acquired immunodeficiencysyndrome”, J Interf Cytokine Res, 1995,15: 261-268.

8. Ansell, S.M., Stenson, M. et al, “cd4+ t-cell immuneresponse to large b-cell non-Hodgkin’s lympohoma predictspatient outcome”, J Clin Oncol, 2001, 19: 720-726.

9. Gopal, S., Martin, K.E. et al., “Clinical presentation, treatmentand outcomes among 65 patients with hiv-associatedlymphoma treated at the University of North Carolina,2000-2010”, aids Res Hum Retrov, 2012, 28: 798-805.

10. Crough, T. y Khanna, R., “Immimobiology of human cytomegalovirus:from bench to bedside”, Clin MicrobiolRev, 2009, 22, 1:76-98.

11. Poole, E., Neves, T.C., Oliveira, M.T., Sinclair, J. y DaSilva, M.C.C., “Human cytomegalovirus interleukin 10homologs: facing the immune system”, Front Cell InfectMicrobiol, 2020, 10: 245.

12. Gandhi, M.K. y Khanna, R., “Human cytomegalovirus”,Lancet Infect Dis, 2004, 4: 725-738.

13. Herndler-Bransdstetter, D., Almanzar, G. y Grubeck-Loebnstein,B. “Cytomegaloviurs and the immune system inold age”, Clin Applied Immunol Rev, 2006, 6: 131-147.

14. Landolfo, S., Gariglio, M. et al., “The human cytomegalovirus”,Pharmacology & Therapeutics, 2003, 98: 269-297.

15. Jackson, S.E., Mason, G.M. y Wills, M.R., “Human cytomegalovirusimmunity and immune evasion”, Virus Res,2011, 157: 151-160.

16. Torres, H.A., Kontoyiannis, D.P., Aguilera, E.A. et al.,“Cytomegalovirus infection in patients with lymphoma”,Clin Lymphoma Myeloma, 2006, 6: 393-398.

17. Grønborg, H.L., Jespersen, S., Hønge, B.L., Jensen-Fangel,S. y Wejse, C., “Review of cytomegalovirus coinfectionin hiv-infected individuals in Africa”, Rev Med Virol,2017, 27 (1): 1-14.

18. Perello, R., Vergara, A., Monclus, E. et al., “Cytomegalovirusinfection in hiv-infected patients in the era of combinationantiretroviral therapy”, bmc Infect Dis, 2019, 19(1): 1030.

19. Svozílková, P., Heissigerová, J. et al., “A possible coincidenceof cytomegalovirus retinitis and intraocularlymphoma in a patient with systemic non-Hodgkin’slymphoma”, Virology J, 2013, 10: 1-8.

20. Christensen-Quick, A., Vanpouille, C., Lisco, A. y Gianella,S., “Cytomegalovirus and hiv persistence: pouringgas on the fire”, aids Res Hum Retroviruses, 2017, 33(S1): S23-30.